超级增强器驱动的SMC4通过表观遗传增强IFI16依赖的STING信号传递来促进骨髓瘤生长
Jiayun Guan1,2, Xuanyi Lin1, Zhenfeng Dai3
1Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
概括
这项研究表明,向SE驱动的SMC4和IFI16-STING通路可以抑制多发性髓瘤的生长. 抑制这种表观遗传网络为这种血液性恶性瘤提供了潜在的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种由异常基因调节驱动的血细胞恶性瘤.
- 超级增强剂 (SE) 是癌症中致癌基因表达的关键调节剂.
- 在MM病原体中SE驱动基因的作用需要进一步阐明.
研究的目的:
- 调查SE驱动的SMC4在促进多发性骨髓瘤生长中的作用.
- 阐明SMC4影响髓瘤进展的分子机制.
- 探索针对已识别的调节电路的治疗潜力.
主要方法:
- 基因枯竭实验评估SMC4对髓瘤细胞的影响.
- 涉及表观遗传调制和信号通路分析的机制研究.
- 药理上抑制IFI16-STING通路,以评估治疗疗效.
主要成果:
- 减少SMC4显著损害了髓瘤细胞的增殖和克隆性.
- 发现SMC4在表观遗传上调节了依赖IFI16的STING信号通路.
- 这种调节导致增多的亲炎性细胞因子,促进亲髓瘤微环境.
- 在MM中建立了SE驱动的SMC4和IFI16/STING基因上调之间的直接联系.
- 对IFI16-STING通路的药理抑制逆转了SMC4.4的致癌作用.
结论:
- 一个涉及SE驱动SMC4和IFI16-STING轴的新型调节电路促进了多发性髓瘤的生长.
- 针对这种表观遗传网络是MM的有希望的治疗策略.
- 对这一途径的干预可能会改善多发性骨髓瘤患者的治疗结果.
相关概念视频
Induced Pluripotent Stem Cells
5.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.8K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K


